| Identification | Back Directory | [Name]
Pemafibrate | [CAS]
848259-27-8 | [Synonyms]
K877
K-877
CS-2768
Pemafibrate
(R)-K 13675
PEMAFIBRATE;K-877;(R)-K 13675
Butanoic acid, 2-[3-[[2-benzoxazolyl[3-(4-methoxyphenoxy)propyl]amino]methyl]phenoxy]-, (2R)- | [Molecular Formula]
C28H30N2O6 | [MOL File]
848259-27-8.mol | [Molecular Weight]
490.55 |
| Chemical Properties | Back Directory | [Melting point ]
98-99 °C(Solv: ethyl acetate (141-78-6); heptane (142-82-5)) | [Boiling point ]
676.7±65.0 °C(Predicted) | [density ]
1.250±0.06 g/cm3(Predicted) | [pka]
3.23±0.10(Predicted) |
| Hazard Information | Back Directory | [Uses]
Pemafibrate is used in the treatment of hyperlipidemia. It also functions as a promising selective PPAR-α modulator for treatment of combined dyslipidemia phase 2 clinical trials with K-877. |
|
|